New Study Finds 40-Percent of Cancer Cases and Almost Half of all Deaths in the U.S. Linked to Modifiable Risk Factors

A new study led by researchers at the American Cancer Society finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

Wren Laboratories Unveils Dynamic Executive Leadership Team and 2024 Commercial Strategy Overhaul

Wren Laboratories announced executive leadership for commercial operations and market expansion. Dr. Abdel Halim is appointed CEO and CSO. Troy Tremaine Appointed to CCO, Dr. Eva Szarek Head of Marketing, and Melissa Ferone director of quality. Expansion includes AI-driven mRNA liquid biopsy genomic assays for biopharma and diagnostics.

New Study Finds Most Eligible U.S. Adults not Getting Screened for Lung Cancer

A new study led by American Cancer Society researchers shows less than one-in-five eligible individuals in the United States were up-to-date with recommended lung cancer screening. The screening uptake was much lower in persons without health insurance or usual source of care and in Southern states with the highest lung cancer burden.

ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy (IMRT) as part of chemoradiation treatment for patients with oropharyngeal (head and neck) cancer.

Evaluating the impact of socioeconomic status on patient satisfaction in radiation oncology

Background: Patient satisfaction (PS) is a critical indicator in evaluating healthcare quality. While the impact of socioeconomic status (SES), on healthcare outcomes is well-documented, its specific connection to PS in the context of radiation oncology remains unclear. This study aims to…

ACS Inaugural Report Shows Mortality for Preventable Cancers Among Native Hawaiian and Other Pacific Islanders in U.S. is 2-3 Times as High as White People

The American Cancer Society today released a first-of-its-kind Cancer Facts & Figures for Asian American, Native Hawaiian, & Other Pacific Islander People, 2024-2026. This report shows that despite limited disaggregated data, there is wide variation in the cancer burden among ethnic groups that make up this fast-growing population.

Unlocking the immune system: cGAS-STING pathway offers new hope for cancer breakthroughs

A groundbreaking study has recognized the cGAS-STING signaling pathway as a formidable ally in the immune system’s battle against cancer. This pivotal discovery may pave the way for innovative immunotherapies capable of amplifying the body’s inherent defenses to detect and eradicate cancer cells, signifying a substantial advance towards more potent cancer treatments.

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

Andrew E. Place, MD, PhD, has been named as Vice President, Pediatric Chief Medical Officer (CMO) at Dana-Farber Cancer Institute (within the Department of Pediatric Oncology) and Boston Children’s Hospital (within the Division of Hematology/Oncology) for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and other Cancer Types Based on Emerging Evidence

Recent NCCN Guidelines updates—along with the supporting evidence—will be presented during the NCCN 2024 Annual Conference held in Orlando, Florida April 5-7, and simultaneously online. Visit to learn more and register.

Five Signs of Colorectal Cancer You Shouldn’t Ignore – Even if You’re a Younger Adult

The recent Cancer Facts & Figures 2024 report from American Cancer Society (ACS) researchers revealed a stark increase in colorectal cancer (CRC) incidence among Americans under the age of 55. In just two decades, CRC has moved up from being the fourth leading cause of cancer death in both younger men and women, to first in men and second in women.

Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice

Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the third Transatlantic Exchange in Oncology Conference will address: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine.The meeting, supported by L’Institut Servier, will be held in-person (witha virtual attendance option) on April 12, 2024, at the Revere Hotel Boston Common and livestreamed virtually on Medscape’s platform.

People With Incarceration History Less Likely to Receive Health Care, Including Cancer Screening in the U.S.

A new study led by researchers at the American Cancer Society (ACS) shows people with an incarceration history had worse access to and receipt of healthcare, including physical exams, blood pressure, blood sugar and cholesterol tests, as well as dental check-ups and breast and colorectal cancer screenings compared with people without incarceration history in the United States. The findings are published today in the Journal of the American Medical Association (JAMA) Health Forum.

Medical experts available for March: Colorectal Cancer Awareness, safe sleep & SIDS, returning to sports after injury, sleep aids, and habits to avoid for your brain health

As you plan healthcare coverage for March, Ochsner Health has experts on standby to cover several topics. Are younger people getting colorectal cancer?: Colorectal cancer has always been a cause for concern among middle-aged and older men and women. However,…

New Research Shows Patients with Cancer who Suffered a Major Adverse Financial Event More Likely to be Diagnosed With Advanced Stage Disease

New findings led by researchers at the American Cancer Society and the National Cancer Institute show more than one-third of cancer patients had a major adverse financial event – bankruptcy, lien, or eviction – before their cancer diagnosis.

Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States

For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.

New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults

A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.

New Study Shows Adults Treated for Non-Small Cell Lung Cancer Vulnerable to Hazards of Wildfires

New research by scientists at the American Cancer Society and the University of California, San Francisco, shows individuals in the United States undergoing radiotherapy for non-small cell lung cancer who are exposed to wildfires near the treating facility have worse overall survival than unexposed individuals.

New Study Finds Limited Documentation of Cost Discussions With Patients Newly Diagnosed With Advanced Cancer

A new study by researchers at the American Cancer Society and the National Cancer Institute, shows only about a quarter of individuals newly diagnosed with advanced cancers had documented physician discussions about costs of care, which may hinder identifying patient needs and tracking outcomes of referrals for assistance.

New Research Shows Patients Receiving Cancer Treatment Understand Health Insurance Basics; Important Knowledge Gaps Remain

A new study by researchers at the American Cancer Society showed among patients receiving outpatient cancer treatment in two sites, most people could understand basic health insurance terms, such as premiums and deductibles.

Inflammatory Breast Cancer: Know the Risks and Warning Signs of This Rare, Fast-Growing Cancer

Inflammatory breast cancer is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society is highlighting IBC to help women be aware of this invasive cancer.

Internationally Recognized Thoracic Oncologist Dr. Taofeek K. Owonikoko Named Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, and University of Maryland Medical Center (UMMC) President and CEO Bert W. O’Malley, MD, announced today that Taofeek K. Owonikoko, MD, PhD, a distinguished physician-scientist with a global reputation in thoracic oncology, has been appointed Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting

Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present new, novel, and expansive radiation oncology data from their clinical research program at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held in San Diego from October 1-4.

Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients

Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain

Patients at JFK University Medical Center to Benefit from $1 Million Gift from the Sarala Bathena Foundation

A $1 million gift to Hackensack Meridian JFK University Medical Center Foundation by the Sarala Bathena Foundation will establish the Sarala Bathena Oncology Patient Assistance Fund at Hackensack Meridian JFK University Medical Center, a not-for-profit medical center located in Edison, NJ.

Childhood Cancer Awareness Month Has Special Meaning for Johns Hopkins Children’s Center Pediatric Oncology Nurse

For the past three years, nurse Lauren Chelenza has cared for hundreds of children with cancer while working on the pediatric oncology inpatient unit at Johns Hopkins Children’s Center in Baltimore. It’s a place she never imagined she’d be working 15 years ago, while going through her own cancer treatment.

Colorectal Cancer Patients in Sub-Saharan Africa Receiving Inadequate Care; Survival After Diagnosis Poor, New Study Shows

In new findings led by researchers at the American Cancer Society, Martin-Luther University in Germany, and many other institutes worldwide, fewer than one in 20 patients diagnosed with potentially curable colorectal cancer received standard of care in Sub-Saharan Africa.